FDA NDC Directory · JSON-LD · Markdown

Sitagliptin and Metformin hydrochloride

NDC 10370-317 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Generic namesitagliptin and metformin hydrochloride
Labeler / ManufacturerPar Health USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA204144
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsSITAGLIPTIN PHOSPHATE (50 mg/1)
METFORMIN HYDROCHLORIDE (500 mg/1)
Marketing started20260724
Package count1

External sources

Source: openFDA. Public-domain (CC0).